#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

An MS diagnosis can depend on where you live, whether you can reach a neurologist and how quickly you can get an MRI. In this episode, Nele speaks with neurologist and neuroimmunologist Dr. Enrique Gomez Figueroa about the gaps in MS care across Mexico. Enrique explains why official case numbers may miss people, what delays diagnosis and why access to an effective treatment can require a lengthy approval process. He also shares what research on switching therapies can tell us—and why listening to people with MS is essential.

In this episode:

Why MS may be underdiagnosed in parts of Mexico Barriers to diagnosis and distinguishing MS from NMOSD and MOGAD Differences between treatments available on paper and in practice When moving to a more effective therapy may be needed How research, patient voices and advocacy can improve access Links and resources Read the full interview and blog post – https://ms-perspektive.de/185-ms-in-mexico/ Atlas of MS: Mexico factsheet Enrique Gomez Figueroa's publications on PubMed Enrique Gomez Figueroa on LinkedIn MSBase study comparing treatment switches — einschließlich des Wechsels zu einer wirksameren Therapie MEXCTRIMS guideline: part I and part II 2024 revisions to the McDonald diagnostic criteria ---

See you soon and try to make the best out of your life,

Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.